Clinical Trials Browser

Phase 2 × Esophageal Neoplasms × Pharmaceutical Preparations × Clear all

NCT00318903 2023-05-25

Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms